Drug trials should include people with more than one disease.
Miniature biomanufacturing kits like this prototype could revolutionize the pharmaceutical industry.
Small-batch brewers are starting to tinker with biologic drugs to meet their own medical needs. A side effect of their success would be a disruption to how big pharma makes and distributes drugs.
Could issues like price manipulation and over-regulation be having an impact on the medicine supply chain?
The reliability of a new guideline for the management of chronic hepatitis C is questionable, given the financial conflicts of interest documented by its authors.
In the run up to the Global Hepatitis Summit 2018, new guidelines for the management of hepatitis C should come under scrutiny – for financial conflict of interest and quality of evidence.
Medical cannabis challenges scientific norms and the usual regulation of medicines.
It doesn’t look like a kidney, but this ‘kidney-on-a-chip’ is a breakthrough for new drug testing.
Researchers who've created a kidney-on-a-chip explain why these kinds of devices are an improvement over traditional ways to test new drugs.
Thousands of people are dying every year of opioid-related overdoses, in an epidemic that traces its roots to 1996 and the introduction of the prescription drug OxyContin. Here, prescription opioids are shown in Toronto during 2017.
THE CANADIAN PRESS/Graeme Roy
Prescription drugs are policed by industry and Health Canada has never prosecuted a drug company for illegally marketing a drug.
High-tech ways to scan nature’s own creations.
Pharmaceutical companies focus on small molecules they've devised – and can easily patent. But nature's already come up with many antibacterial compounds that drug designers could use to make medicines.
In this March 18, 2011 photo, Cassidy Hempel waved at hospital staff as she was being treated for a rare disorder. Her mother Chris, left, fought to gain permission for an experimental drug.
AP Photo/Marcio Jose Sanchez
Congress has sent a bill to the White House. It gives terminally-ill patients more false hope than chances for a cure.
Moving a robot is like manipulating a molecule.
Researchers use an algorithm designed to help robots move to figure out what's possible when designing new molecules in a promising class of pharmaceuticals.
How a technology born from finance – the blockchain – can help the pharmaceutical industry to carry out clinical trials that protect patients.
We’re a nation of medication hoarders, and that can be dangerous.
If you look into your kitchen or bathroom cabinet, chances are you'd find some unused medicine, much of it expired. Here's what to do with it.
Singapore 2010 Youth Olympics/Flickr
The choke factor is visible in tournament-style athletics competitions, and should teach managers about incentives.
As the government moves ahead with its industrial plan, a new report signals it will have to start doing things differently.
Methylprednisolone, the corticosteroid that’s used to treat serious asthma attacks, works by reducing inflammation.
A trial of methylprednisolone in kidney patients was halted recently because of safety concerns. But this doesn't affect people taking the drug for asthma, arthritis or other inflammatory conditions.
The cells inside this bioreactor are the real pharmaceutical factories.
Rather than being designed by chemists, this class of pharmaceuticals is produced by living cells. Here's where they come from and how they work.
3D bioprinted channel, representing a blood vessel within a hydrogel that mimics human tissue.
Forget, Heiny, Derme, Mitterberger, Shastri
3D bioprinting of living cells and materials may contribute to faster and cheaper ways to create effective new drugs - and even reduce animal testing.
Ohio is fighting to hold drug companies accountable for their role in the opioid epidemic.
The state of Ohio filed a lawsuit against opioid manufacturers. Will their legal arguments hold up in court – and what will it mean for other cities and states going after big pharma?
Canada spends more per capita on prescription drugs than most other OECD countries.
Canada is the only nation with a broad public health system lacking universal coverage for pharmaceuticals. Despite fears that pharmacare would be too costly, it could end up saving Canadians money.
If doctors prescribe generic drugs rather than their brand name equivalents, most times patients benefit.
A push towards prescribing generic medications rather than their branded equivalents, as flagged in the budget, may have benefits beyond simple cost savings.